PHA Pharmagest Interactive SA

EQUASENS (ex Pharmagest Interactive): H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH THE BROKERAGE FIRM GILBERT DUPONT

EQUASENS (ex Pharmagest Interactive): H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT WITH THE BROKERAGE FIRM GILBERT DUPONT

Villers-lès-Nancy, 21 July 2022 – 6:00 p.m. (CET)

PRESS RELEASE

H1 2022 HALF-YEAR REPORT ON THE LIQUIDITY AGREEMENT

WITH THE BROKERAGE FIRM GILBERT DUPONT

Under the liquidity agreement administered by the brokerage firm, Gilbert Dupont, on behalf of , liquidity account holdings at 30 June 2021 were as follows:

- Number of shares: 2,779

- Cash balance: €149,326.28

For the 2022 first half, a summary of total transactions is provided below:

PURCHASES42,335 shares€3,403,363.601,728 transactions
SALES41,146 shares€3,273,914.361,861 transactions

For information, liquidity account holdings were reported as follows:

in the half-year report of 31 December 2021:

- Number of shares: 1,590

- Cash balance: €278,775.56

when the liquidity agreement was first implemented:

- Number of shares: 2,219

- Cash balance: 50 000,00 €.

This liquidity agreement is executed in accordance with decision No. 2018-01 of 2 July 2018 of the Autorité des Marchés Financiers (“AMF”) establishing accepted market practices in relation to liquidity agreements for shares.

About

With more than 1,200 employees fulfilling a vital role as “Citizens in the Service of Health and Well-Being”, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.

With operations in France, Italy, Belgium, Luxembourg and the United Kingdom, Equasens Group is currently developing the leading healthcare platform and a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

Listed on Euronext Paris™ - Compartment A

Included in the Euronext Tech Leaders segment and the European Rising Tech label

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC® SMALL and CAC® All-Tradable by inclusion

Eligible for the Deferred Settlement Service (“Service à Réglement Différé” - SRD) and equity savings accounts invested in small and mid caps (PEA-PME).

ISIN: FR0012882389 - Ticker Code: EQS

For all the latest news on Equasens Group go to

CONTACTS

Analyst and Investor Relations:

Chief Administrative and Financial Officer: Jean-Yves SAMSON

Tel. +33 (0)3 83 15 90 67 -

Media Relations:

FIN’EXTENSO - Isabelle APRILE

+33 (0)1 39 97 61 22 -   

APPENDIX

 PurchasesSales
 Number of transactionsNumber of sharesNumber of transactionsNumber of sharesNumber of transactionsNumber of shares
TOTAL1 72842.3353.403.363.601 86141.1463.273.914.36
03/01/20222565761229.711417016056.01
04/01/2022840637572.781429527465
05/01/2022074268093.490807368
06/01/20223454348572.385807166
07/01/2022824021265.012048343069.98
10/01/20222356449412.325504455
11/01/20227180154751831427135.69
12/01/20221733929185.292854146717.08
13/01/20222144838470.392338332982.2
14/01/20221847240243916814390.39
17/01/2022622519160.012448541533.51
18/01/20222557549049.63526022230.99
19/01/2022025121319.89028023927.51
20/01/20223897547.21528924742.1
21/01/2022064554372.98020016980
24/01/2022034928220.38000
25/01/20221431824841.711136528798.5
26/01/202215039251427021236.2
27/01/2022033626069.8062248480.98
28/01/20221431824877.112239531022
31/01/20220002633126513.99
01/02/2022000045536913.6
02/02/20221117714497.891422718655
03/02/20222768154773.112164.2
04/02/20222153842051.32813810856.1
07/02/202246551383066252656.87
08/02/20223255844022.81621116891.79
09/02/2022000075760908.6
10/02/20222950941146.49616613625.6
11/02/20222462449153.983057945792.47
14/02/2022044234067.590251920
15/02/2022817613393.645100678491.54
16/02/20223648738019.219997926.9
17/02/20221839629925.2116462
18/02/20222942831877.7717513120
21/02/20221831122369.33463309
22/02/20222036525308.111944831401.48
23/02/20221728720386.992141729847.82
24/02/20222752335820.113199569426.52
25/02/20227856045.53162345120.28
28/02/20221619114199.992765048590.3
01/03/20222245934390.12824018277.99
02/03/20222441330423.112665849088.38
03/03/20221746935310.592840630881.9
04/03/20223757342328.61525418947.51
07/03/20221531321460.52354538344.51
08/03/20222232523614.991845933913.08
09/03/20222957141879.62357142260.62
10/03/20221237827984.42253840046.3
11/03/2022816412215.612246735156.18
14/03/202224030602031023781.81
15/03/20223048536848.021251897.5
16/03/2022000039930910.21
17/03/20221845035379.322428422445.8
18/03/20221136228444.42132825898.58
21/03/20227150119451730023935.41
22/03/2022517213901.92630424651.3
23/03/20222262350980.531215312647.81
24/03/2022062350717.12021017144.11
25/03/20221131055.63254644995.59
28/03/20222478063846.982962351636.92
29/03/20220002850542480.2
30/03/20221230926160.311624620965.99
31/03/2022924320746.492132027495.1
01/04/2022935530986.992531827807.51
04/04/2022020518215.99024421809.5
05/04/202221515455331504500
06/04/20221341536370.521939534837.5
07/04/20222048042142.71935831504.11
08/04/20221550243717.021312110617.5
11/04/20221724020521.8516514147
12/04/2022026422512.2070260274
13/04/20228192165471317815371.4
14/04/20221224921471.592038533282.4
19/04/20222656548410.61000
20/04/20222332127093.41417614981.81
21/04/20221724020086.992121012.8
22/04/20222242534593.09000
25/04/20221538930741.191938430443.21
26/04/20222039530804.31000
27/04/20221532224580.11132224734.78
28/04/2022713110151.41333425987.71
29/04/20221743033207.0151118636
02/05/20221036627945.312864949838.59
03/05/20221177.23160547338.59
04/05/20221620115876.211121917548.1
05/05/2022835028066.011848739518.98
06/05/20222558746337.61329823747.11
09/05/20222442332844.811826820868.2
10/05/20221425119338.62543333527.8
11/05/20222141331833.591527221174.79
12/05/20222435426772.49000
13/05/20221175.22359645800.51
16/05/202215038801834026454.89
17/05/2022628522141.911854342571.53
18/05/20221624419252.412840532067.62
19/05/20221429623440.391442333699.39
20/05/2022617414038.811124519791.81
23/05/20226196158392126821746.51
24/05/20222251941922.23917314031.6
25/05/20224776175.56927423
26/05/20221418514882.61413110562.01
27/05/202251229843.22351041486.1
30/05/20221019116122.12426522352.19
31/05/20222869757794.823322716.8
01/06/2022619015448.011725120566.89
02/06/202258066021633727993.11
03/06/20221323219484.22134228828.62
06/06/20221837030991.391116113467.01
07/06/2022727022371.012754845824.2
08/06/20223276164124.61956047423.71
09/06/20222950842303.418917583.2
10/06/20223255745458000
13/06/20221632024731.392028722276.39
14/06/20221831823871.45987451.4
15/06/20221336926821.912759543828.3
16/06/20222344632633.698715325
17/06/202281168426.213273554261.89
20/06/2022000039729878.5
21/06/2022056843020.77023818261.6
22/06/2022038028387.48048336209.79
23/06/20222155741781.572255041388.99
24/06/20220002640831223.91
27/06/20224856687.52429423186.99
28/06/20226228181461829723806.01
29/06/20221340331694.023493859.5
30/06/20221645434398.991340630902

Attachment



EN
21/07/2022

Underlying

PHAPharmagest Interactive SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pharmagest Interactive SA

 PRESS RELEASE
Free
PHA Pharmagest Inte...

EQUASENS ANNONCE SON AGENDA FINANCIER 2026

EQUASENS ANNONCE SON AGENDA FINANCIER 2026 Villers-lès-Nancy, 10 décembre 2026, 18h00 CET – Equasens (isin : FR0012882389 – Mnémo : EQS), leader des solutions numériques pour les professionnels de santé, annonce son agenda financier pour l’exercice 2026. ÉvénementsDatesChiffre d’affaires annuel 20255 février 2026 (après bourse)Résultats annuels 202530 mars 2026 (avant bourse)Chiffre d’affaires du 1er trimestre 202629 avril 2026 (après bourse)Assemblée Générale Annuelle25 juin 2026Chiffre d’affaires du 1er semestre 202630 juillet 2026 (après bourse)Résultats du 1er semestre 202628 septembre ...

December 10, 2025 1 EN
 PRESS RELEASE
Free
PHA Pharmagest Inte...

EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR

EQUASENS ANNOUNCES ITS 2026 FINANCIAL CALENDAR Villers-lès-Nancy, December 10, 2026, 6:00 p.m. CET – Equasens (ISIN: FR 0012882389 – Ticker: EQS), a leader in digital solutions for healthcare professionals, announces its financial calendar for the 2026 financial year. EventsDates2025 annual revenueFebruary 5, 2026 (after market close)2025 annual resultsMarch 30, 2026 (before market opens)2026 Q1 revenueApril 29, 2026 (after market close)Annual General MeetingJune 25, 20262026 Half-year revenueJuly 30, 2026 (after market close)2026 Half-year resultsSeptember 28, 2026 (before market opens)202...

December 10, 2025 1 EN
Adrian Pehl ... (+2)
  • Adrian Pehl
  • Marc Lavaud
PHA PHARMAGEST INTERACTIVE SA
FII LISI SA
VOE VOESTALPINE AG
SDF K+S AG
INH INDUS HOLDING AG
PAL PALFINGER AG
SEM SEMPERIT HOLDING AG
ADN1 ADESSO AG
PAT PATRIZIA AG
SAX STROEER SE & CO. KGAA
POST OSTERREICHISCHE POST AG
TWEKA TKH GROUP N.V. CERT
CSM CORBION NV
FACC FACC AG
JUN3 JUNGHEINRICH AG PREF
JEN JENOPTIK AG
KTA KNAUS TABBERT
SFQ SAF-HOLLAND SE
VT5 VT5 ACQUISITION COMPANY AG
SPG SPRINGER NATURE AG & CO. KGAA
CAN CANAL+
11/12/25 November 12, 2025 1 EN
Adrian Pehl ... (+2)
  • Adrian Pehl
  • Marc Lavaud
PHA PHARMAGEST INTERACTIVE SA
FII LISI SA
VOE VOESTALPINE AG
SDF K+S AG
INH INDUS HOLDING AG
PAL PALFINGER AG
SEM SEMPERIT HOLDING AG
ADN1 ADESSO AG
PAT PATRIZIA AG
SAX STROEER SE & CO. KGAA
POST OSTERREICHISCHE POST AG
TWEKA TKH GROUP N.V. CERT
CSM CORBION NV
FACC FACC AG
JUN3 JUNGHEINRICH AG PREF
JEN JENOPTIK AG
KTA KNAUS TABBERT
SFQ SAF-HOLLAND SE
VT5 VT5 ACQUISITION COMPANY AG
SPG SPRINGER NATURE AG & CO. KGAA
CAN CANAL+
11/12/25 November 12, 2025 1 FR
Aurelien Sivignon
  • Aurelien Sivignon
PHA Pharmagest Inte...

Equasens : e-health pure player with modest valuation

Equasens provides IT solutions and software for the healthcare industry. Historically positioned in the pharmacy segment (market leader in France, >40% market share), its global expansion (Italy, Germany) and business diversification (nursing homes, hospitals, private practitioners, etc.), should facilitate the return to a dynamic growth trajectory (2025-28 CAGR estimated at +7%) after two challenging years. Given the necessary investments (R&D, salesforce), we believe 2025 will mark a low for m...

PHA PHARMAGEST INTERACTIVE SA
11/12/25 November 12, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch